Meeting Banner
Abstract #1705

Comparison Between 31P MRS and 18F-FDG PET for Response Prediction in Non-Hodgkins Lymphoma

Mihaela Rata1, Nandita Desouza1, Michael Germuska1, Michael Partridge2, Martin O. Leach1, Geoffrey S. Payne1

1MRI Unit, CR-UK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; 2Radiotherapy and Imaging, CR-UK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom

18FDG PET uptake represents the gold standard technique for staging aggressive non-Hodgkins lymphomas (NHL) but quantified SUVmax at outset is also predictive of treatment response. The phosphomonester peak normalized by the total amount of -NTP (nucleoside triphosphates) on 31P-MRS has also demonstrated promise as a predictive biomarker: This study explores the relationship between the predictive biomarkers. The absence of significant correlation between the glucose uptake using 18FDG-PET and PME/bNTP using 31P MRS suggests that they may contain complementary information on response prediction

Keywords

acquisition acronyms addition amount anatomical arias assessed biomedical blood bottom breast cancer cell cellular clearly coded cohort coils complementary complete consisted contain correlated correlation criteria cycles days defining detected determine deviation diffuse disease early emission encoding energy england example explore extent fitting follicular giving glucose gradient grants gray health heart highlighted hospital inorganic institute kingdom lack leach lymphoma lymphomas martin mass masses measured metabolism metabolites month months normalized orange original orthogonal outcome panel panels parametric partial partridge patients peak phosphate planning pool positron potential predict predicting prediction predictive processed promise protocol pulse quality quantified radiographers radiotherapy reached reflected regarding relationship reported residual residue responders response royal sets slice software spectra spectral spectroscopy spectrum stand standardized steady steps subtypes successfully suggest suggests surface tomography treated treatment tumors unit unknown uptake utilization vector ventricle whether width